CHICAGO (PRWEB) October 15, 2005
The Kidney Cancer Association (KCA) today announced the appointment of Katherine S. Phillion, B.S. in chemical engineering, a founder of the Southwest Kidney Cancer Foundation, and a ten-year survivor of metastatic kidney cancer, as Patient-Advocate Liaison to the Fourth International Kidney Cancer Symposium (http://kidneycancersymposium.org), October 21-23, in Chicago.
The Foundation was established in Pearland, Texas in 2003 as a non-profit organization devoted to providing mutual support for patients and care-givers, sharing information and coping experiences and discussing protocols and therapies. The Foundation also provides educational seminars for patients, care-givers and medical professionals and raises funds for kidney cancer research and treatment.
Ms. Phillion participated as patient advocate in the NCI sponsored Kidney/Bladder Cancers Progress Review Group (PRG) in November 2001. The PRG accepted the charge of then-NCI Director Dr. Richard Klausner to develop a national plan for the next 5 years of kidney and bladder cancer research. From collaborative efforts of the scientists, clinicians, industry representatives, and patient advocates who participated in the PRG Roundtable Meeting, a final report was issued. The priorities outlined in this report are a blueprint for progress toward preventing, diagnosing, and treating kidney and bladder cancers http://prg.cancer.gov/kidney/finalreport.html.
She was a panelist representing the Patient Voice in Research Forum coordinated by Research America! at M.D. Anderson Cancer Center. Research Partners for our Nations Health: Academia, Industry and Government was designed to convey the benefits of collaboration between public and privately funded medical and health research and to increase awareness of the contributions and interdependence of academia, industry, government and the media.
The KCA serves more than 70-thousand constituents in 102 nations from offices in suburban Chicago. Its mission is the global eradication of death and suffering due to renal cancers. More than 200 scientists and physicians are expected to attend the Fourth International Kidney Cancer Symposium.